An observational study of patients with acute promyelocytic leukemia

Study ID: EA9131

Simplified patient care strategy in decreasing early death in patients with acute promyelocytic leukemia

This trial is studying how well a patient care strategy, which includes the use of simplified care guidelines and expert support, works in prolonging the lives of patients diagnosed with acute promyelocytic leukemia (APL). Patients receive standard of care for APL, and are followed for one year.

In this observational study, researchers are studying how well simplified patient care strategy works in decreasing early death in patients with APL.

Inclusion criteria:

  • Confirmed to have a diagnosis of APL defined as:
    • Positive t(15:17) by FISH or conventional karyotype
    • Positive promyelocytic leukemia/retinoic acid receptor PML/RAR alpha by PCR
  • Patients must accept treatment and supportive care guidelines
  • Referrals must be made as early as possible but no later than five calendar days after ATRA therapy is initiated; consent can be obtained up until day seven or earlier

Additional schema information (PDF)

Inclusion Snapshot

  • Must have been recently diagnosed with APL.
  • Must be willing to accept treatment and supportive care guidelines as outlined by your physician.

Contact Information

Lankenau Institute for Medical Research trial